Immune thrombocytopenic purpura
Conditions
Interventions
Experimental group:Tamiflu
control group:Nil
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
14 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. People who are willing to sign the informed consent voluntarily and follow the research program; 2. Conform to the diagnostic criteria of ITP; (1) decreased platelet counts in many laboratory tests; (2) Without splenmegaly; (3) Elevated or normal number of megakaryocytes in the bone morrow examination with dysmaturity; (4) With exception of other secondary thrombocytopenic purpura; 3. Age 14 to 65 years old,male or female; 4. Without ditinct dysfunction of heart, lung, liver, kidney and so on; 5. Platelet counts <30*10^9/L in two consecutive times(not in same day); 6. Initial or refractory patiets.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation; 2. People who are specifically allergic and intolerant to medicines whic is used for treatment; 3. Severe cardiovascular, respiratory, digestive system disease; 4. A history of thrombosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet count; | — |
Countries
China
Contacts
Public ContactHan Yue
The First Affiliated Hospital of Soochow University
Outcome results
None listed